Applying the skin sensitisation adverse outcome pathway (AOP) to quantitative risk assessment.
Maxwell G, MacKay C, Cubberley R, Davies M, Gellatly N, Glavin S, Gouin T, Jacquoilleot S, Moore C, Pendlington R, Saib O, Sheffield D, Stark R, Summerfield V.
Maxwell G, et al.
Toxicol In Vitro. 2014 Feb;28(1):8-12. doi: 10.1016/j.tiv.2013.10.013. Epub 2013 Oct 31.
Toxicol In Vitro. 2014.
PMID: 24184331